(1 - 10 from 13
)
Clyde Biosciences Closes Series A Investment — Clyde Biosciences...
www.clydebio.com
Sinclair Dunlop, Managing Partner at Epidarex Capital, said: “Clyde Biosciences' unique technology is already improving the safety profile of ...
BIA Networking Lunch - Edinburgh - The BioIndustry Association
events.bioindustry.org
... NovaBiotics, Dr Mike Capaldi, Commercial Director, Edinburgh BioQuarter and Sinclair Dunlop, Managing Partner, Epidarex Capital discussing this important ...
Lilly invests in UK life sciences via biotech fund - PMLiVE
www.pmlive.com
"The completion of our fund is a significant validation of the UK's life science research base," said Epidarex' managing partner Sinclair Dunlop.
sorted by relevance / date